iifl-logo

Tata Nifty MidSmall Healthcare Index Fund Reg G

Tata Nifty MidSmall Healthcare Index Fund Reg G

Fund Name

Tata Mutual Fund

Scheme Name

Tata Nifty MidSmall Healthcare Index Fund Reg G

AMC

Tata Mutual Fund

Type

:  Open

Category

Equity - Index

Launch Date

08-Apr-2024

Fund Manager

Nitin Sharma

Net Assets (Rs. cr)

207.04

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Tata Nifty MidSmall Healthcare Index Fund Reg G - Nav Details

Nav Date

:  10-Sep-2026

NAV [Rs.]

:  -

Buy/Resale Price [Rs.]

-

Sell/Repurchase Price [Rs.]

-

Entry Load %

Exit Load %

Tata Nifty MidSmall Healthcare Index Fund Reg G- NAV Chart

Tata Nifty MidSmall Healthcare Index Fund Reg G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.92
-0.21
8.71
21.96
17.24
-
-
19.3
Category Avg
-0.84
-2.22
5.05
4.92
3.15
11.2
9.39
7.27
Category Best
3.62
5.49
19.4
30.37
33.85
29.68
17.39
28.48
Category Worst
-5.14
-6.39
-4.8
-11.86
-20.46
-1.65
5.07
-18.66

Tata Nifty MidSmall Healthcare Index Fund Reg G- Latest Dividends

No Records Found

Tata Nifty MidSmall Healthcare Index Fund Reg G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityLaurus LabsPharmaceuticals & Biotechnology11.2212840224.58
EquityLupinPharmaceuticals & Biotechnology8.018014517.53
EquityAurobindo PharmaPharmaceuticals & Biotechnology7.169134815.68
EquityFortis Health.Healthcare Services7.1217197815.59
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology5.624969012.32
EquityAlkem LabPharmaceuticals & Biotechnology4.701931010.29
EquityBioconPharmaceuticals & Biotechnology4.432354519.70
EquityIpca Labs.Pharmaceuticals & Biotechnology4.13458419.05
EquityMankind PharmaPharmaceuticals & Biotechnology4.13373629.03
EquityGland PharmaPharmaceuticals & Biotechnology3.46262967.58
EquitySai LifePharmaceuticals & Biotechnology3.03455336.64
EquityNeuland Labs.Pharmaceuticals & Biotechnology2.9928466.54
EquityKrishna Institu.Healthcare Services2.95855536.46
EquityAster DM QualityHealthcare Services2.88835566.31
EquityAcutaas ChemicalPharmaceuticals & Biotechnology2.47171155.40
EquityWockhardtPharmaceuticals & Biotechnology2.34272535.13
EquityAjanta PharmaPharmaceuticals & Biotechnology2.29138995.00
EquityDr Lal PathlabsHealthcare Services2.27257194.97
EquityAbbott IndiaPharmaceuticals & Biotechnology2.0317194.44
EquityPiramal PharmaPharmaceuticals & Biotechnology2.012052644.40
EquityNarayana HrudayaHealthcare Services1.98228024.34
EquityGlobal HealthHealthcare Services1.91282594.18
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology1.90136594.16
EquityGranules IndiaPharmaceuticals & Biotechnology1.81478913.96
EquityOneSource Speci.Pharmaceuticals & Biotechnology1.80259523.94
EquitySyngene Intl.Healthcare Services1.15627422.51
EquityNatco PharmaPharmaceuticals & Biotechnology1.14296502.49
EquityCohance LifePharmaceuticals & Biotechnology1.12536952.44
EquityPfizerPharmaceuticals & Biotechnology1.0750012.34
EquityPoly MedicureHealthcare Equipment & Supplies1.01126052.21

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Tata Mutual Fund
Incorporation Date:
15-Mar-1994
Total Assets Managed (Cr.):
2,31,388.30
Trustee/s:
Mr. Kersi Bhagat-Associat, Tata Trustee Company Priv
Chairman:
NA
CEO / MD:
Anand Vardarajan
CIO:
NA
President:
NA
Director/s:
Mr. Gangan Rai
Compliance Officer/s:
Upesh Shah, Mr. Padmanabhan Ramanatha
Investor Service Officer/s:
NA
Fund Manager/s:
Nitin Sharma
Auditors:
NA

OTHER INFORMATION

Registered Office:
1903, B-Wing, Parinee Crescenzo, G-Block, Bandra Kurla Complex, Bandra East Mumbai - 400051
Contact Nos:
022 62827777
Fax:
022 2261 3782.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.